Skip to content

Clinical trials

Hemophilia B trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20121
20172
20184
20191
20201
20211
20222
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer8
Genzyme, a Sanofi Company2
Baxalta now part of Shire1
Bayer1
CSL Behring1
ISU Abxis Co., Ltd.1
Konkuk University Medical Center1
Novo Nordisk A/S1
TiumBio Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B17
Hemophilia A11
Hemorrhage4
Blood Coagulation Disorders3
Hematologic Diseases3
Blood Coagulation Disorders, Inherited2
Coagulation Protein Disorders2
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Hemorrhagic Disorders2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.